Cefamandole

Cefamandole

File:Cefamandole.svg
Clinical data
Pregnancy category	AU: B1
Routes of administration	Intramuscular, intravenous
ATC code	J01DC03 (WHO)
Legal status
Legal status	UK: POM (Prescription only) Discontinued (US)
Pharmacokinetic data
Protein binding	75%
Elimination half-life	48 minutes
Excretion	Mostly renal, as unchanged drug
Identifiers
IUPAC name (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}- 3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	34444-01-4 42540-40-9 (nafate)
PubChem CID	456255
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C18H18N6O5S2
Molar mass	462.505 g/mol

WikiDoc Resources for Cefamandole
Articles
Most recent articles on Cefamandole Most cited articles on Cefamandole Review articles on Cefamandole Articles on Cefamandole in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefamandole Images of Cefamandole Photos of Cefamandole Podcasts & MP3s on Cefamandole Videos on Cefamandole
Evidence Based Medicine
Cochrane Collaboration on Cefamandole Bandolier on Cefamandole TRIP on Cefamandole
Clinical Trials
Ongoing Trials on Cefamandole at Clinical Trials.gov Trial results on Cefamandole Clinical Trials on Cefamandole at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefamandole NICE Guidance on Cefamandole NHS PRODIGY Guidance FDA on Cefamandole CDC on Cefamandole
Books
Books on Cefamandole
News
Cefamandole in the news Be alerted to news on Cefamandole News trends on Cefamandole
Commentary
Blogs on Cefamandole
Definitions
Definitions of Cefamandole
Patient Resources / Community
Patient resources on Cefamandole Discussion groups on Cefamandole Patient Handouts on Cefamandole Directions to Hospitals Treating Cefamandole Risk calculators and risk factors for Cefamandole
Healthcare Provider Resources
Symptoms of Cefamandole Causes & Risk Factors for Cefamandole Diagnostic studies for Cefamandole Treatment of Cefamandole
Continuing Medical Education (CME)
CME Programs on Cefamandole
International
Cefamandole en Espanol Cefamandole en Francais
Business
Cefamandole in the Marketplace Patents on Cefamandole
Experimental / Informatics
List of terms related to Cefamandole

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cefamandole (INN, also known as cephamandole) is a broad-spectrum cephalosporin antibiotic. The clinically used form of cefamandole is the formate ester cefamandole nafate, a prodrug which is administered parenterally.

Cefamandole is no longer available in the United States.

Template:WS